These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38504824)

  • 1. Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation.
    Rahikainen R; Rijal P; Tan TK; Wu HJ; Andersson AC; Barrett JR; Bowden TA; Draper SJ; Townsend AR; Howarth M
    Angew Chem Weinheim Bergstr Ger; 2021 Jan; 133(1):325-334. PubMed ID: 38504824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation.
    Rahikainen R; Rijal P; Tan TK; Wu HJ; Andersson AC; Barrett JR; Bowden TA; Draper SJ; Townsend AR; Howarth M
    Angew Chem Int Ed Engl; 2021 Jan; 60(1):321-330. PubMed ID: 32886840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SpyTag/SpyCatcher display of influenza M2e peptide on norovirus-like particle provides stronger immunization than direct genetic fusion.
    Lampinen V; Gröhn S; Soppela S; Blazevic V; Hytönen VP; Hankaniemi MM
    Front Cell Infect Microbiol; 2023; 13():1216364. PubMed ID: 37424789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technology.
    Heinimäki S; Lampinen V; Tamminen K; Hankaniemi MM; Malm M; Hytönen VP; Blazevic V
    Virology; 2022 Jan; 566():89-97. PubMed ID: 34894525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses.
    Janitzek CM; Matondo S; Thrane S; Nielsen MA; Kavishe R; Mwakalinga SB; Theander TG; Salanti A; Sander AF
    Malar J; 2016 Nov; 15(1):545. PubMed ID: 27825348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Display of Streptococcus iniae α-Enolase on the Surface of Virus-Like Particles (VLPs) of Nervous Necrosis Virus (NNV) Using SpyTag/SpyCatcher.
    Yang JI; Kim KH
    Mar Biotechnol (NY); 2022 Dec; 24(6):1066-1072. PubMed ID: 36171522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial superglue enables easy development of efficient virus-like particle based vaccines.
    Thrane S; Janitzek CM; Matondo S; Resende M; Gustavsson T; de Jongh WA; Clemmensen S; Roeffen W; van de Vegte-Bolmer M; van Gemert GJ; Sauerwein R; Schiller JT; Nielsen MA; Theander TG; Salanti A; Sander AF
    J Nanobiotechnology; 2016 Apr; 14():30. PubMed ID: 27117585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modular and self-adjuvanted multivalent vaccine platform based on porcine circovirus virus-like nanoparticles.
    Liu ZH; Deng ZF; Lu Y; Fang WH; He F
    J Nanobiotechnology; 2022 Nov; 20(1):493. PubMed ID: 36424615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue.
    Brune KD; Howarth M
    Front Immunol; 2018; 9():1432. PubMed ID: 29997617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response.
    Marini A; Zhou Y; Li Y; Taylor IJ; Leneghan DB; Jin J; Zaric M; Mekhaiel D; Long CA; Miura K; Biswas S
    Front Immunol; 2019; 10():2931. PubMed ID: 31921185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoprotein.
    Ximba P; Chapman R; Meyers A; Margolin E; van Diepen MT; Sander AF; Woodward J; Moore PL; Williamson AL; Rybicki EP
    Nanotechnology; 2022 Sep; 33(48):. PubMed ID: 35882111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platform.
    Chevillard C; Amen A; Besson S; Hannani D; Bally I; Dettling V; Gout E; Moreau CJ; Buisson M; Gallet S; Fenel D; Vassal-Stermann E; Schoehn G; Poignard P; Dagher MC; Fender P
    Mol Ther; 2022 May; 30(5):1913-1925. PubMed ID: 35151843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent protein display on Hepatitis B core-like particles in plants through the in vivo use of the SpyTag/SpyCatcher system.
    Peyret H; Ponndorf D; Meshcheriakova Y; Richardson J; Lomonossoff GP
    Sci Rep; 2020 Oct; 10(1):17095. PubMed ID: 33051543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudotyping Improves the Yield of Functional SARS-CoV-2 Virus-like Particles (VLPs) as Tools for Vaccine and Therapeutic Development.
    Zak AJ; Hoang T; Yee CM; Rizvi SM; Prabhu P; Wen F
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge.
    Wong TY; Russ BP; Lee KS; Miller OA; Kang J; Cooper M; Winters MT; Rodriguez-Aponte SA; Dalvie NC; Johnston RS; Rader NA; Wong ZY; Cyphert HA; Martinez I; Shaligram U; Batwal S; Lothe R; Chandrasekaran R; Nagar G; Rajurkar M; Rao H; Bevere JR; Barbier M; Love JC; Damron FH
    mSphere; 2022 Aug; 7(4):e0024322. PubMed ID: 35968964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of Modular Protein Display Efficiency in SpyTag-Implemented Norovirus-like Particles.
    Boonyakida J; Khoris IM; Nasrin F; Park EY
    Biomacromolecules; 2023 Jan; 24(1):308-318. PubMed ID: 36475654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nanoparticle vaccine displaying the ookinete PSOP25 antigen elicits transmission-blocking antibody response against Plasmodium berghei.
    Yao G; Min H; Yu X; Liu F; Cui L; Cao Y
    Parasit Vectors; 2023 Nov; 16(1):403. PubMed ID: 37932796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines.
    Leneghan DB; Miura K; Taylor IJ; Li Y; Jin J; Brune KD; Bachmann MF; Howarth M; Long CA; Biswas S
    Sci Rep; 2017 Jun; 7(1):3811. PubMed ID: 28630474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display.
    Singh SK; Thrane S; Janitzek CM; Nielsen MA; Theander TG; Theisen M; Salanti A; Sander AF
    Vaccine; 2017 Jun; 35(30):3726-3732. PubMed ID: 28578824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Self-Adjuvanted, Modular, Antigenic VLP for Rapid Response to Influenza Virus Variability.
    Sharma J; Shepardson K; Johns LL; Wellham J; Avera J; Schwarz B; Rynda-Apple A; Douglas T
    ACS Appl Mater Interfaces; 2020 Apr; 12(16):18211-18224. PubMed ID: 32233444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.